LABL 56.78 Multi-Color Corp $LABL Hit a 52 week high of

Investors Face Rough Waters Okay, let’s dive into this latest mess at Lincoln Educational Services Corp. (NASDAQ:LINC). Things aren't smelling too rosy over at their headquarters. If you've got shares here, you’ll know what I mean. Back in early May, the folks running Lincoln threw a garden party talking up a 19.5% growth in student starts. Who wouldn’t get behind...

Grappling with Medicare's Gaps Most folks hear Medicare and feel a sigh of relief—thinking it's a catch-all net for healthcare in your golden years. But hold on, when it comes to long-term care, Medicare's got more holes than Swiss cheese. Cindy Couyoumjian from Cinergy Financial lays it out pretty clear: Medicare doesn't cover what it calls 'custodial care'—you know,...

Papa John's: Doughy Deceit or Strategic Misfire? Once in a while, a corporation trips over its own ambitious production line, and Papa John’s (NASDAQ:PZZA) is the latest contestant to make headlines for all the wrong reasons. Investors in this pizza powerhouse are being called to the courtroom as a class action lawsuit unfolds, marking a turbulent stage in the...

A New Chapter for GDIT with a Veteran Leader Big shoes to fill? Nah, more like Amy Johnson was made for these shoes. Stepping up as president of General Dynamics Information Technology (GDIT) on November 3, she’s got 27 years of experience under her belt, all from General Dynamics' own backyard. This ain't her first rodeo. From tightrope-walking the perils of defense...

Strengthening the Bond: A Four-Decade Journey With fireworks of diplomacy and cooperation lighting up, Shanghai and Hamburg marked the 40th anniversary of their friendship with an ambition to deepen and broaden ties. These cities, separated by continents but united by their maritime spirit, decided to toast not just the past but also the future. This isn't just some fancy...

AbbVie's Injection Makes Waves in Crohn's Treatment Here's a bit of medicine shake-up for you. AbbVie just snagged FDA approval for its subcutaneous SKYRIZI—specifically designed for adults battling moderately to severely active Crohn's disease. This news isn't just a blip on the radar; it's significant for patients and the healthcare landscape. We're talking about new...

Empowering the HS Community with Innovations Look, if you’ve walked a mile in someone else's shoes—particularly ones dealing with hidradenitis suppurativa (HS)—you’d know what a relentless grind managing those exuding wounds can be. Dimora Medical, known for navigating the tricky territory of wound care, threw its hat into the ring at the HS Connect Empower...

Innventure's DarkNX Project: From Boon to Bane The stock market is no stranger to seismic shifts, but Innventure, Inc.'s recent plunge is a testament to the catastrophic impact missteps can unleash. This whole DarkNX debacle feels more like a meticulous car wreck than a business evolution. Unpacking the Allegations Sitting comfortably under the NASDAQ:INV ticker,...

Unexpected Surge in Northern Virginia's Inventory Walking around Fairfax these days, you might feel like you're in a time warp, especially if you're tracking the housing market. See, while the rest of the country's housing market groans under sluggish sales and creeping prices, Northern Virginia's doing a dance of its own. Inventory's ballooning faster than a parade...

Anticipating Hexagon's Third Quarter 2026 Results Hexagon Composites ASA, based out of Oslo, Norway, is setting the stage to release its third quarter 2026 financial results. Mark your calendars for November 6, 2026, at the early bird hour of 07:00 am CET. For those of us keen on dissecting the numbers, that's when the real action begins. Executive Insights Await A...

J.B. Hunt’s Recent Performance Overview J.B. Hunt Transport Services (NASDAQ: JBHT) has reported a modest increase in its share price as markets digest its latest earnings report. The company has posted total operating revenue of $2.93 billion for the current quarter, which is consistent with earlier projections from the second quarter of the year. Despite this revenue...

Establishment Labs Holdings Inc. (NASDAQ: ESTA) made waves back in 2024 when they snagged FDA approval for their Motiva implants. This was no small feat; it represented a real turning point in the world of breast aesthetics and reconstruction. The chatter on the trading floor was electric, with analysts scrambling to decipher what this meant for market positioning. Motiva...

Promising Neuromodulation Therapy for Alzheimer’s Disease Sinaptica Therapeutics, Inc., a pioneering force in personalized neuromodulation treatments, recently shared notable findings from a rigorous 52-week Phase 2 study targeting Alzheimer’s disease. This clinical-stage company focuses on innovative solutions to address neurodegenerative disorders, particularly...

Tim Woodward Celebrated as a CNN Hero for Animal Welfare The leadership of Tim Woodward, the executive director of the national nonprofit Animal Rescue Corps, has gained significant recognition as he is honored as a CNN Hero. This acknowledgment is a testament to his unwavering dedication and commitment to the welfare of animals across the United States. Dedication to...

Empower Brands Welcomes Felicia Reeves as Chief Marketing Officer Empower Brands, a distinguished multi-brand franchisor specializing in both premium commercial and residential services, proudly announces the appointment of Felicia Reeves as its new Chief Marketing Officer. With her extensive experience in driving marketing growth, Reeves is set to propel the brand's...